Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from BAX

Baxter International Earnings Preview: What to Expect

Baxter International is set to announce its first-quarter results this month, with analysts predicting a single-digit decline in the company's earnings.

Barchart

How Is Baxter's Stock Performance Compared to Other Medical Devices Stocks?

Baxter has notably underperformed the Medical Devices industry over the past year, and analysts are cautious about the stock’s prospects.

Barchart

Are Wall Street Analysts Predicting Baxter International Stock Will Climb or Sink?

As Baxter International has underperformed the broader market over the past year, Wall Street analysts maintain a cautious outlook on the stock’s prospects.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

What You Need To Know Ahead of Baxter International's Earnings Release

Baxter International is set to announce its fourth-quarter results soon, with analysts predicting a single-digit decline in the company's earnings.

Barchart

Baxter International Stock: Is BAX Underperforming the Health Care Sector?

Baxter International has lagged the broader health care sector by a wide margin over the past year, and analysts are taking a guarded stance on its outlook.

Barchart

Is Wall Street Bullish or Bearish on Baxter International Stock?

As Baxter International has underperformed the broader market over the past year, Wall Street analysts maintain a cautious outlook on the stock’s prospects.

Barchart

Baxter Trims Annual Outlook Again, Stock Hits 52-Week

Baxter International Inc. (NYSE:BAX) stock hit a 52-week low on Thursday, after the company again lowered its 2025 guidance.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

What to Expect From Baxter International’s Next Quarterly Earnings Report

Baxter International is slated to report its third-quarter earnings this week, with analysts expecting a low double-digit decline in profit amid ongoing industry and macroeconomic headwinds.

Barchart

Is Baxter International Stock Underperforming the Dow?

Baxter International has considerably underperformed the Dow over the past year, and analysts are cautious about the stock’s prospects.

Barchart

Are Wall Street Analysts Bullish on Baxter International Stock?

While Baxter International has lagged the broader market over the past year, Wall Street analysts remain cautiously optimistic about its future potential.

Barchart

What to Expect From Baxter International's Q2 2025 Earnings Report

Baxter International is expected to release its second-quarter earnings next month, with analysts anticipating a low double-digit profit decline.

Barchart

Is Baxter International Stock Underperforming the Nasdaq?

Baxter International has underperformed the Nasdaq over the past year, but analysts are cautiously optimistic about the stock’s prospects.

Barchart

Baxter Dury enters his brat era: 'I want to escape the trap of mature man music'

Baxter Dury’s new album Allbarone is a dancefloor filler resulting from a love of Charli xcx and a producer who wouldn’t listen to him

Evening Standard

What Are Wall Street Analysts' Target Price for Baxter International Stock?

Although Baxter International has underperformed the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Cycling News

Giro d'Abruzzo: Georg Zimmermann wins final GC as Ivo Oliveira scores another stage victory

Oliveira attacks with Sjoerd Bax but peloton keeps them close

Barchart

Here's What to Expect From Baxter International’s Next Earnings Report

As Baxter International approaches its first-quarter earnings report early next month, analysts are forecasting a double-digit decline in profits.

Barchart

Is Baxter International Stock Underperforming the S&P 500?

Despite its underperformance over the past year, Baxter International has notably outpaced the S&P 500 in the recent months and analysts remain cautiously optimistic about the stock’s prospects.

Barchart

Baxter International Stock: Is Wall Street Bullish or Bearish?

Baxter International has underperformed the broader market over the past year, and analysts are cautious about the stock’s prospects.

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Earnings Preview: What To Expect From Baxter International's Report

As Baxter International prepares to report its fourth-quarter earnings next month, analysts expect a double-digit profit dip.

Barchart

How Is Baxter International's Stock Performance Compared to Other Medical Devices Stocks?

Baxter International has lagged behind its peers in the medical devices industry over the past three months, and analysts are cautious about the stock's prospects.

Barchart

Baxter International Stock: Analyst Estimates & Ratings

Due to Baxter International’s underperformance relative to the broader market over the past year, Wall Street analysts remain cautious about the stock’s prospects.

Barchart

Baxter International's Quarterly Earnings Preview: What You Need to Know

Baxter International is all set to announce its third-quarter results next month, with analysts predicting a double-digit growth in the company's earnings.

Barchart

Baxter Stock: Is BAX Underperforming the Healthcare Sector?

Baxter has underperformed the healthcare sector over the past year, and analysts are cautious about the stock’s prospects.

Barchart

Is Becton, Dickinson, and Company Stock Underperforming the Nasdaq?

Becton, Dickinson, and Company have recently underperformed in the Nasdaq, but Wall Street analysts are optimistic about the stock’s prospects.

StockNews.com

3 High-Growth MedTech Stocks to Buy

The medtech industry’s long-term growth is fueled by growing demand for medical devices, adoption of cutting-edge technologies, and improved efficiency. Thus, it could be ideal to buy fundamentally solid medtech stocks Baxter International (BAX), Zimmer Biomet Holdings (ZBH), and Embecta (EMBC) poised for substantial growth. Keep reading.

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Becton, Dickinson, and Company

Q365 Pro Cycling Team

20 stories

VF Group

19 stories

Zimmer Biomet Holdings

16 stories

EMBC

10 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.